Skip to main content
. 2013 Dec 18;11(2):412–418. doi: 10.1007/s13311-013-0243-0

Fig. 1.

Fig. 1

Mean photoparoxysmal responses (PPR) range across 4 (1–6 h) treatment and baseline test periods, each on different days, for 6 patients with eye closure condition. Mean PPR was not reduced by carbamazepine (CBZ), but was reduced by levetiracetam (LEV) in all patients compared to placebo. *SPR = standardized photosensitive range; #patient 2 did not receive LEV per protocol because it was a background antiepileptic drug